J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Vol 247, Issue 2 pp 273-288
Copyright © 1975 by The Physiological Society
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daniel, P M
Right arrow Articles by Pratt, O E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daniel, P M
Right arrow Articles by Pratt, O E

Insulin-stimulated entry of glucose into muscle in vivo as a major factor in the regulation of blood glucose.

P M Daniel, E R Love and O E Pratt

1. The entry of glucose into the pectoralis major muscle of living rats was measured over a wide range of plasma glucose concentrations. A technique was used by which steady concentrations of substances are maintained in the circulation throughout the experiments. 2. Raising the concentration of glucose in the plasma caused saturation of the mechanism by which it is transported into muscle. Estimates of the values of the kinetic constants for this transport system were: Kt, 34 mumole ml-1 and V, 1-2 mumole min-1-g-1 muscle. 3. When the plasma glucose concentration was raised up to at least twelve times normal, there was no sign of saturation of the transport system in insulin-treated animals. This finding could be explained if insulin increased greatly both V and Kt for glucose transport. 4. Insulin increased the rate of entry of glucose into muscle over the entire range of plasma glucose concentrations studied (4-8 mumole ml.-1). There was evidence that endogenous insulin produced a similar increase in entry rate some 10 min after the injection of glucose. Fasting, which is associated with a decrease in insulin level, depressed the rate of entry. In hyperglycaemia insulin caused a rise in the concentration of glucose within the muscle cells. 5. The insulin-induced increase in the rate of glucose entry into muscle ensured that approximately 25% of an I.V. dose of glucose entered the muscle cells of insulin-treated animals within one minute. This illustrates the quantitatively important regulatory role that skeletal muscle plays in these circumstances in limiting the extent of a rise in circulating glucose.




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. L. Gavete, M. A. Martin, C. Alvarez, and F. Escriva
Maternal Food Restriction Enhances Insulin-Induced GLUT-4 Translocation and Insulin Signaling Pathway in Skeletal Muscle from Suckling Rats
Endocrinology, August 1, 2005; 146(8): 3368 - 3378.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. M. Wallace, J. C. Levy, and D. R. Matthews
Use and Abuse of HOMA Modeling
Diabetes Care, June 1, 2004; 27(6): 1487 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. S. Anderson, J. He, J. Flowers-Ziegler, S. U. Devaskar, and W. W. Hay Jr.
Effects of selective hyperglycemia and hyperinsulinemia on glucose transporters in fetal ovine skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1256 - R1263.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. E. Nikoulina, T. P. Ciaraldi, L. Carter, S. Mudaliar, K. S. Park, and R. R. Henry
Impaired Muscle Glycogen Synthase in Type 2 Diabetes Is Associated with Diminished Phosphatidylinositol 3-Kinase Activation
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4307 - 4314.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Ragolia, N. Duddy, and N. Begum
Effect of an Asp905Tyr Mutation of the Glycogen-Associated Regulatory Subunit of Protein Phosphatase-1 on the Regulation of Glycogen Synthesis by Insulin and Cyclic Adenosine 3',5'-Monophosphate Agonists
Mol. Endocrinol., October 1, 1999; 13(10): 1773 - 1783.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 The Physiological Society.